Michael Huang

Michael L.
Huang was the founder of Neurovive Pharmaceutical Asia, Inc., founded in 2014, where the title held was Chief Executive Officer from 2014 to 2017.
Current jobs include Director at Windgap Medical, Inc. since 2021, Director at Viracta Subsidiary, Inc. since 2019, Director at Regenacy Pharmaceuticals LLC, Director at Point Robotics Medtech, Inc., and Director at Elixiron Immunotherapeutics (Cayman) Ltd. since 2019.
Former jobs include Director at Sunesis Pharmaceuticals, Inc., Director at Fractyl Health, Inc., Independent Director at Frequency Therapeutics, Inc., Independent Director at Viracta Therapeutics, Inc. from 2019 to 2022, Director at Digestive Health Specialists PC, and Head-Investor Relations at TWi Pharmaceuticals, Inc. Education includes undergraduate studies at The University of Texas at Austin, graduate studies at The University of Texas at Arlington, and an MBA from Jones Graduate School of Business.